Democratic Committee Leaders and CMS Present Latest Challenges to Theranos

 Email not displaying correctly? View it in your browser.
  Lab and Pathology Insider Logo  
July 12, 2016  
placeholder ENFORCEMENT
Democratic Committee Leaders and CMS Present Latest Challenges to Theranos
By Kelly Hardy Briganti, Editorial Director, G2 Intelligence
Both the Centers for Medicare & Medicaid Services (CMS) and some high ranking Democratic Committee members had some bad news for…
Read More
placeholder EMERGING TESTS
FDA Approves First Molecular Test of Antibiotic Resistance Directly From Patient Samples
By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies
The U.S. Food and Drug Administration (FDA) recently approved the first rapid molecular test for detection of antibiotic resistance directly from…
Read More
placeholder PRECISION MEDICINE
New FDA Guidances Address NGS and Supporting Variant Databases
By Kelly Hardy Briganti, Editorial Director, G2 Intelligence
Promoting flexibility and efficiency, the U.S. Food and Drug Administration (FDA) issued two draft guidances last week addressing oversight of…
Read More
placeholder PARTNERSHIPS
Trovagene, University of Michigan Enter Pact to Focus on KRAS-Based Pancreatic Cancer Detection, Treatment
By Ron Shinkman, Editor, Laboratory Industry Report
Trovagene has entered into a pact with the University of Michigan Comprehensive Cancer Center in order to develop a molecular test for the earlier detection and…
Read More
Follow on Twitter |  Forward to a Friend

For questions concerning delivery of this email, please contact customer service at:
(888) 729-2315 | customerservice@plainlanguagemedia.com

Copyright © 2016, All rights reserved.
Plain Language Media LLLP
PO Box 509, New London, CT 06320